Essential business, market and company information
Reports 2006
Veterinary Drug Residues and MRLs Published 30/11/2006 Click here to view Chapter 1 This essential management report offers a comprehensive, global overview of residue incidence by species and market. It details major causes, detection techniques and technology, and control and prevention methods.
Animal Pharm's Top 20: 2006 Edition Published: 01/10/06 Click here to view Chapter 1 A key source of information and analysis on the 20 largest companies in the sector. Invest in this report to keep informed of the performance of your potential competitors, collaborators or customers.
Veterinary Diagnostics & Equipment: The Global Market Published: 30/09/06 Click here to view Chapter 1 Profiling 70 of the leading companies operating in all aspects of the veterinary diagnostic market worldwide, the report analyzes the size and features of the diagnostics market in the context of the overall animal health market, including an examination of market drivers and constraints and regulatory issues.
World Animal Health Markets Published: 31/08/06 Click here to view Chapter 1 The world animal health market was worth US$17.4 billion in 2005. This report provides an overview of the global market in terms of structure and recent growth, and examines in detail 15 national markets which, together, generate some 85% of sales in the sector.
Generics in the Animal Health Industry Published: 31/05/2006 Click here to view Chapter 1 This report examines the latest developments in the animal health industry relating to ‘generics’ — the term traditionally used to differentiate non-proprietary drugs from the original, branded versions.
Avian 'Flu: The role of animal health companies in its control and eradication Published: 31/01/2006 Click here to view Chapter 1 This report investigates the technical background to avian flu, and details the range of identification, control and eradication strategies that are available. It identifies the potential role of animal health companies in these efforts, specifically with respect to diagnostics and vaccines, and discusses these sectors in terms of their strengths and weaknesses, and key R&D objectives to improve their effectiveness.